EDAP TMS SA, the global leader in robotic energy-based therapies, today announced that Prof. Gil Dubernard, Head of the Gynecology Department at Croix-Rousse University Hospital, Lyon, France, will deliver a presentation at the 6th European Endometriosis Congress, which is being held June 15-17 in Bordeaux, France. EDAP will occupy booth #23 during the congress.
Marc Oczachowski, EDAP’s Chairman and Chief Executive Officer, said, “We have been working vigorously to explore the potential of HIFU as a treatment option for rectal endometriosis for some time. We are pleased to be able to share insights at this highly specialized gathering of disease experts and look forward to Prof. Dubernard sharing his preliminary results to the most prominent endometriosis surgeons in Europe.”
“Endometriosis is a painful and debilitating condition that could benefit greatly from less invasive treatment options, and our studies to date suggest that HIFU is a conservative new approach that holds great promise in this indication,” stated Prof. Dubernard. “We look forward to final results from our ongoing Phase 2 multicenter study later this year that we believe will confirm the efficacy and safety of HIFU as a potential treatment for endometriosis and strongly support its continued development.”
Details of the presentation is as follows:
Treatment of Symptomatic Rectal Endometriosis with HIFU (High Intensity Focused Ultrasound)
Date: Friday, June 17th
Time: 12:30pm-1:00pm CEST (6:30am-7:00am EDT)
Presenter: Gil Dubernard, MD PhD, Hospices Civils de Lyon
The full congress program can be found here.
Source: EDAP TMS.